LCTX
Lineage Cell Therapeutics, Inc.stockNYSEAMERICAN
At CloseNov 18, 2026 3:59:59 PM EST
0.85USD+3.935%(+0.03)1,220,903
Pre-marketNov 18, 2026 9:25:30 AM EST
0.8151USD-0.086%(-0.0007)
After-hoursNov 18, 2026 4:49:30 PM EST
0.816USD-3.762%(-0.032)
LCTX Financials
In Q3 FY 2026 (ended ), Lineage Cell Therapeutics, Inc. (LCTX) reported revenue of $1.43M, net income of $4.23M, operating cash flow of −$5.62M, and assets of $100.11M (filed ).
Loading business breakdowns…